,i #aaeth ,,congress #b;d ,session ,h4 ,r4 #egab ,,in ,,the ,,house ,,of ,,representatives ,may #h1 #bjah,mr4 ,schrader 7for himself and ,mr4 ,welch7 introduced the following bill2 which was referred to the ,committee on ,energy and ,commerce ,a ,,bill ,to amend title ,,xix of the ,social ,security ,act to compel manufacturers to correct inaccurate classification data reported to the ,medicaid rebate program1 and for other purposes4 #a4 ,short title ,this ,act may be cited as the ,medicaid ,drug ,rebate ,accountability ,act4 #b4 ,authority to compel manufacturers to correct inaccurate classification data reported to ,medicaid rebate program ,section #aibg7;b77#c7 of the ,social ,security ,act 7#db ,u4,s4,c4 #acifr-#h7;b77#c77 is amended by adding at the end the following new subparagraph3 7,e7 ,remedy with respect to inaccurate classification data 7i7 ,correction of inaccurate classification data ,in the case that the ,secretary determines that drug classification data reported on or after ,september #cj1 #bjah1 by a manufacturer under this paragraph1 with respect to a covered outpatient drug of such manufacturer1 provides an inaccurate classification for such drug1 the ,secretary shall require such manufacturer to correct1 within a #cj-;day period1 the classification for such drug4 7ii7 ,civil monetary penalty ,in the case of a manufacturer who fails to correct the classification of a covered outpatient drug within a #cj-;day period pursuant to clause 7i71 the ,secretary shall1 beginning the day after the end of such #cj-;day period1 require such manufacturer to pay a civil monetary penalty of #ajj1jjj per day until the date on which the manufacturer corrects such classification4 7iii7 ,classification defined ,for purposes of this subparagraph1 the term classification means identification or designation as one of the following3 7,i7 ,a single source drug4 7,,ii7 ,an innovator multiple source drug4 7,,iii7 ,a noninnovator multiple source drug4 4